FDA Conditionally Approves XTENT's Stent System
The Food and Drug Administration conditionally approved XTENT Inc.'s (Nasdaq: XTNT) application to begin clinical trials for its drug eluting stent system. Shares of the medical device company surged 40 cents to $1.90.
